Literature DB >> 29800485

Time-lapse systems for embryo incubation and assessment in assisted reproduction.

Sarah Armstrong1, Priya Bhide, Vanessa Jordan, Allan Pacey, Cindy Farquhar.   

Abstract

BACKGROUND: Embryo incubation and assessment is a vital step in assisted reproductive technology (ART). Traditionally, embryo assessment has been achieved by removing embryos from a conventional incubator daily for quality assessment by an embryologist, under a light microscope. Over recent years time-lapse systems have been developed which can take digital images of embryos at frequent time intervals. This allows embryologists, with or without the assistance of embryo selection software, to assess the quality of the embryos without physically removing them from the incubator.The potential advantages of a time-lapse system (TLS) include the ability to maintain a stable culture environment, therefore limiting the exposure of embryos to changes in gas composition, temperature and movement. A TLS has the potential advantage of improving embryo selection for ART treatment by utilising additional information gained through continuously monitoring embryo development. Use of a TLS often adds significant extra cost onto an in vitro fertilisation (IVF) cycle.
OBJECTIVES: To determine the effect of a TLS compared to conventional embryo incubation and assessment on clinical outcomes in couples undergoing ART. SEARCH
METHODS: We used standard methodology recommended by Cochrane. We searched the Cochrane Gynaecology and Fertility (CGF) Group trials register, CENTRAL, MEDLINE, Embase, CINAHL and two trials registers on 2 August 2017. SELECTION CRITERIA: We included randomised controlled trials (RCTs) in the following comparisons: comparing a TLS, with or without embryo selection software, versus conventional incubation with morphological assessment; and TLS with embryo selection software versus TLS without embryo selection software among couples undergoing ART. DATA COLLECTION AND ANALYSIS: We used standard methodological procedures recommended by Cochrane. The primary review outcomes were live birth, miscarriage and stillbirth. Secondary outcomes were clinical pregnancy and cumulative clinical pregnancy. We reported quality of the evidence for important outcomes using GRADE methodology. We made the following comparisons.TLS with conventional morphological assessment of still TLS images versus conventional incubation and assessmentTLS utilising embryo selection software versus TLS with conventional morphological assessment of still TLS images TLS utilising embryo selection software versus conventional incubation and assessment MAIN
RESULTS: We included eight RCTs (N = 2303 women). The quality of the evidence ranged from very low to moderate. The main limitations were imprecision and risk of bias associated with lack of blinding of participants and researchers, and indirectness secondary to significant heterogeneity between interventions in some studies. There were no data on cumulative clinical pregnancy.TLS with conventional morphological assessment of still TLS images versus conventional incubation and assessmentThere is no evidence of a difference between the interventions in terms of live birth rates (odds ratio (OR) 0.73, 95% CI 0.47 to 1.13, 2 RCTs, N = 440, I2 = 11% , moderate-quality evidence) and may also be no evidence of difference in miscarriage rates (OR 2.25, 95% CI 0.84 to 6.02, 2 RCTs, N = 440, I2 = 44%, low-quality evidence). The evidence suggests that if the live birth rate associated with conventional incubation and assessment is 33%, the rate with use of TLS with conventional morphological assessment of still TLS images is between 19% and 36%; and that if the miscarriage rate with conventional incubation is 3%, the rate associated with conventional morphological assessment of still TLS images would be between 3% and 18%. There is no evidence of a difference between the interventions in the stillbirth rate (OR 1.00, 95% CI 0.13 to 7.49, 1 RCT, N = 76, low-quality evidence). There is no evidence of a difference between the interventions in clinical pregnancy rates (OR 0.88, 95% CI 0.58 to 1.33, 3 RCTs, N = 489, I2 = 0%, moderate-quality evidence).TLS utilising embryo selection software versus TLS with conventional morphological assessment of still TLS imagesNo data were available on live birth or stillbirth. We are uncertain whether TLS utilising embryo selection software influences miscarriage rates (OR 1.39, 95% CI 0.64 to 3.01, 2 RCTs, N = 463, I2 = 0%, very low-quality evidence) and there may be no difference in clinical pregnancy rates (OR 0.97, 95% CI 0.67 to 1.42, 2 RCTs, N = 463, I2 = 0%, low-quality evidence). The evidence suggests that if the miscarriage rate associated with assessment of still TLS images is 5%, the rate with embryo selection software would be between 3% and 14%.TLS utilising embryo selection software versus conventional incubation and assessmentThere is no evidence of a difference between TLS utilising embryo selection software and conventional incubation improving live birth rates (OR 1.21, 95% CI 0.96 to 1.54, 2 RCTs, N = 1017, I2 = 0%, very low-quality evidence). We are uncertain whether TLS influences miscarriage rates (OR 0.73, 95% CI 0.49 to 1.08, 3 RCTs, N = 1351, I2 = 0%, very low-quality evidence). The evidence suggests that if the live birth rate associated with no TLS is 38%, the rate with use of conventional incubation would be between 36% and 58%, and that if miscarriage rate with conventional incubation is 9%, the rate associated with TLS would be between 4% and 10%. No data on stillbirths were available. It was uncertain whether the intervention influenced clinical pregnancy rates (OR 1.17, 95% CI 0.94 to 1.45, 3 RCTs, N = 1351, I2 = 42%, very low-quality evidence). AUTHORS'
CONCLUSIONS: There is insufficient evidence of differences in live birth, miscarriage, stillbirth or clinical pregnancy to choose between TLS, with or without embryo selection software, and conventional incubation. The studies were at high risk of bias for randomisation and allocation concealment, the result should be interpreted with extreme caution.

Entities:  

Mesh:

Year:  2018        PMID: 29800485      PMCID: PMC6494546          DOI: 10.1002/14651858.CD011320.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  33 in total

1.  Early cleavage of in-vitro fertilized human embryos to the 2-cell stage: a novel indicator of embryo quality and viability.

Authors:  Y Shoukir; A Campana; T Farley; D Sakkas
Journal:  Hum Reprod       Date:  1997-07       Impact factor: 6.918

Review 2.  Choosing the best embryo by time lapse versus standard morphology.

Authors:  Kirstine Kirkegaard; Aishling Ahlström; Hans Jakob Ingerslev; Thorir Hardarson
Journal:  Fertil Steril       Date:  2014-12-17       Impact factor: 7.329

Review 3.  Time-lapse systems for embryo incubation and assessment in assisted reproduction.

Authors:  Sarah Armstrong; Nicola Arroll; Lynsey M Cree; Vanessa Jordan; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2015-02-27

4.  Embryo incubation and selection in a time-lapse monitoring system improves pregnancy outcome compared with a standard incubator: a retrospective cohort study.

Authors:  Marcos Meseguer; Irene Rubio; Maria Cruz; Natalia Basile; Julian Marcos; Antonio Requena
Journal:  Fertil Steril       Date:  2012-09-10       Impact factor: 7.329

5.  Systematic review on clinical outcomes following selection of human preimplantation embryos with time-lapse monitoring.

Authors:  Thomas Freour; Natalia Basile; Paul Barriere; Marcos Meseguer
Journal:  Hum Reprod Update       Date:  2014-10-07       Impact factor: 15.610

Review 6.  Time-lapse embryo imaging for improving reproductive outcomes: systematic review and meta-analysis.

Authors:  L T Polanski; M A Coelho Neto; C O Nastri; P A Navarro; R A Ferriani; N Raine-Fenning; W P Martins
Journal:  Ultrasound Obstet Gynecol       Date:  2014-09-08       Impact factor: 7.299

7.  No benefit of culturing embryos in a closed system compared with a conventional incubator in terms of number of good quality embryos: results from an RCT.

Authors:  H Park; C Bergh; U Selleskog; A Thurin-Kjellberg; K Lundin
Journal:  Hum Reprod       Date:  2014-11-28       Impact factor: 6.918

8.  Morphokinetic parameters of early embryo development via time lapse monitoring and their effect on embryo selection and ICSI outcomes: a prospective cohort study.

Authors:  Charalampos Siristatidis; Maria Aggeliki Komitopoulou; Andreas Makris; Afrodite Sialakouma; Mitrodora Botzaki; George Mastorakos; George Salamalekis; Stefano Bettocchi; Giles Anthony Palmer
Journal:  J Assist Reprod Genet       Date:  2015-01-24       Impact factor: 3.412

9.  Embryo quality, blastocyst and ongoing pregnancy rates in oocyte donation patients whose embryos were monitored by time-lapse imaging.

Authors:  María Cruz; Blanca Gadea; Nicolás Garrido; Kamilla Søe Pedersen; Mar Martínez; Inma Pérez-Cano; Manuel Muñoz; Marcos Meseguer
Journal:  J Assist Reprod Genet       Date:  2011-03-11       Impact factor: 3.412

10.  Sequential embryo scoring as a predictor of aneuploidy in poor-prognosis patients.

Authors:  A Finn; L Scott; Thomas O'Leary; D Davies; J Hill
Journal:  Reprod Biomed Online       Date:  2010-05-13       Impact factor: 3.828

View more
  16 in total

1.  Which embryo selection method should be offered to the patients?

Authors:  Peter Kovacs; Harry J Lieman
Journal:  J Assist Reprod Genet       Date:  2019-04-05       Impact factor: 3.412

2.  Time-lapse systems for embryo incubation and assessment in assisted reproduction.

Authors:  Sarah Armstrong; Priya Bhide; Vanessa Jordan; Allan Pacey; Jane Marjoribanks; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2019-05-29

3.  An integrated investigation of oocyte developmental competence: expression of key genes in human cumulus cells, morphokinetics of early divisions, blastulation, and euploidy.

Authors:  C Scarica; D Cimadomo; L Dovere; A Giancani; M Stoppa; A Capalbo; F M Ubaldi; L Rienzi; R Canipari
Journal:  J Assist Reprod Genet       Date:  2019-02-01       Impact factor: 3.412

4.  Between-laboratory reproducibility of time-lapse embryo selection using qualitative and quantitative parameters: a systematic review and meta-analysis.

Authors:  Yanhe Liu; Fang Qi; Phillip Matson; Dean E Morbeck; Ben W Mol; Sai Zhao; Masoud Afnan
Journal:  J Assist Reprod Genet       Date:  2020-05-02       Impact factor: 3.412

Review 5.  Artificial intelligence and machine learning for human reproduction and embryology presented at ASRM and ESHRE 2018.

Authors:  Carol Lynn Curchoe; Charles L Bormann
Journal:  J Assist Reprod Genet       Date:  2019-01-28       Impact factor: 3.412

6.  Temperature of embryo culture for assisted reproduction.

Authors:  Nora A Baak; Astrid Ep Cantineau; Cindy Farquhar; Daniel R Brison
Journal:  Cochrane Database Syst Rev       Date:  2019-09-17

7.  Human frozen-thawed blastocyst morphokinetics observed using time-lapse cinematography reflects the number of trophectoderm cells.

Authors:  Takuya Iwasawa; Kazumasa Takahashi; Mayumi Goto; Mibuki Anzai; Hiromitsu Shirasawa; Wataru Sato; Yukiyo Kumazawa; Yukihiro Terada
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

8.  Can novel early non-invasive biomarkers of embryo quality be identified with time-lapse imaging to predict live birth?

Authors:  J Barberet; C Bruno; E Valot; C Antunes-Nunes; L Jonval; J Chammas; C Choux; P Ginod; P Sagot; A Soudry-Faure; P Fauque
Journal:  Hum Reprod       Date:  2019-08-01       Impact factor: 6.918

Review 9.  Artificial intelligence in reproductive medicine.

Authors:  Renjie Wang; Wei Pan; Lei Jin; Yuehan Li; Yudi Geng; Chun Gao; Gang Chen; Hui Wang; Ding Ma; Shujie Liao
Journal:  Reproduction       Date:  2019-10       Impact factor: 3.906

10.  Good practice recommendations for the use of time-lapse technology.

Authors:  Susanna Apter; Thomas Ebner; Thomas Freour; Yves Guns; Borut Kovacic; Nathalie Le Clef; Monica Marques; Marcos Meseguer; Debbie Montjean; Ioannis Sfontouris; Roger Sturmey; Giovanni Coticchio
Journal:  Hum Reprod Open       Date:  2020-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.